Nicotinell Fruktmint 1 mg Komprimerad sugtablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

nicotinell fruktmint 1 mg komprimerad sugtablett

glaxosmithkline consumer healthcare a/s - nikotinditartratdihydrat - komprimerad sugtablett - 1 mg - maltitol, flytande hjälpämne; nikotinditartratdihydrat 3,072 mg aktiv substans; aspartam hjälpämne - nikotin

Betamint 1 mg Komprimerad sugtablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

betamint 1 mg komprimerad sugtablett

glaxosmithkline consumer healthcare a/s - nikotinditartratdihydrat - komprimerad sugtablett - 1 mg - maltitol, flytande hjälpämne; nikotinditartratdihydrat 3,072 mg aktiv substans; aspartam hjälpämne - nikotin

Nicotinell Fruktmint 2 mg Komprimerad sugtablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

nicotinell fruktmint 2 mg komprimerad sugtablett

glaxosmithkline consumer healthcare a/s - nikotinditartratdihydrat - komprimerad sugtablett - 2 mg - aspartam hjälpämne; nikotinditartratdihydrat 6,144 mg aktiv substans; maltitol, flytande hjälpämne - nikotin

Betamint 2 mg Komprimerad sugtablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

betamint 2 mg komprimerad sugtablett

glaxosmithkline consumer healthcare a/s - nikotinditartratdihydrat - komprimerad sugtablett - 2 mg - aspartam hjälpämne; nikotinditartratdihydrat 6,144 mg aktiv substans; maltitol, flytande hjälpämne - nikotin

Sugammadex Piramal Europeiska unionen - svenska - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskulär blockade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Mylan Europeiska unionen - svenska - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Europeiska unionen - svenska - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed Europeiska unionen - svenska - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversering av neuromuskulär blockad som induceras av rocuronium eller vekuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq Europeiska unionen - svenska - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Avansor 100 mg/ml Injektionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sugammadex avansor 100 mg/ml injektionsvätska, lösning

avansor pharma oy - sugammadexnatrium - injektionsvätska, lösning - 100 mg/ml - sugammadexnatrium 108 mg aktiv substans